These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 22496474

  • 41. Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
    Fellows SE, Rosini JM, Curtis JA, Volz EG.
    J Emerg Med; 2013 Feb; 44(2):e221-5. PubMed ID: 22595629
    [Abstract] [Full Text] [Related]

  • 42. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.
    Bytzer P, Connolly SJ, Yang S, Ezekowitz M, Formella S, Reilly PA, Aisenberg J.
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):246-52.e1-5. PubMed ID: 23103906
    [Abstract] [Full Text] [Related]

  • 43. Hemopericardium and cardiac tamponade associated with dabigatran use.
    Dy EA, Shiltz DL.
    Ann Pharmacother; 2012 Mar; 46(7-8):e18. PubMed ID: 22786838
    [Abstract] [Full Text] [Related]

  • 44. Determination of dabigatran in human plasma samples.
    Harenberg J, Giese C, Marx S, Krämer R.
    Semin Thromb Hemost; 2012 Feb; 38(1):16-22. PubMed ID: 22314599
    [Abstract] [Full Text] [Related]

  • 45. Treatment of dabigatran-associated bleeding: case report and review of the literature.
    Harinstein LM, Morgan JW, Russo N.
    J Pharm Pract; 2013 Jun; 26(3):264-9. PubMed ID: 23160864
    [Abstract] [Full Text] [Related]

  • 46. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [Abstract] [Full Text] [Related]

  • 47. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.
    Garber ST, Sivakumar W, Schmidt RH.
    J Neurosurg; 2012 May; 116(5):1093-6. PubMed ID: 22394293
    [Abstract] [Full Text] [Related]

  • 48. Interpretation of point-of-care INR results in patients treated with dabigatran.
    van Ryn J, Baruch L, Clemens A.
    Am J Med; 2012 Apr; 125(4):417-20. PubMed ID: 22306274
    [Abstract] [Full Text] [Related]

  • 49. Rash associated with dabigatran etexilate.
    To K, Reynolds C, Spinler SA.
    Pharmacotherapy; 2013 Mar; 33(3):e23-7. PubMed ID: 23400964
    [Abstract] [Full Text] [Related]

  • 50. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG.
    Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
    [No Abstract] [Full Text] [Related]

  • 51. The use of dabigatran in elderly patients.
    Legrand M, Mateo J, Aribaud A, Ginisty S, Eftekhari P, Huy PT, Drouet L, Payen D.
    Arch Intern Med; 2011 Jul 25; 171(14):1285-6. PubMed ID: 21788545
    [Abstract] [Full Text] [Related]

  • 52. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
    Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S, Hach-Wunderle V, Lindhoff-Last E, Riess H, Schellong S, Schinzel H, Bode C.
    Hamostaseologie; 2012 Jul 25; 32(4):294-305. PubMed ID: 23114798
    [Abstract] [Full Text] [Related]

  • 53. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.
    J Cardiol; 2013 Aug 25; 62(2):121-6. PubMed ID: 23680005
    [Abstract] [Full Text] [Related]

  • 54. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV, Gage BF.
    Circulation; 2011 Jun 07; 123(22):2562-70. PubMed ID: 21606397
    [Abstract] [Full Text] [Related]

  • 55. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct 07; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 56. Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation.
    Moore CH, Snashall J, Boniface K, Scott J.
    Am J Emerg Med; 2012 Nov 07; 30(9):2082.e1-2. PubMed ID: 22196949
    [Abstract] [Full Text] [Related]

  • 57. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D, Hull R, Fareed J.
    Int Angiol; 2011 Jun 07; 30(3):199-211. PubMed ID: 21617603
    [Abstract] [Full Text] [Related]

  • 58. What is the role of hemodialysis for dabigatran-associated major bleeding?
    Kim B, Garcia DA.
    Hematology Am Soc Hematol Educ Program; 2014 Dec 05; 2014(1):514-7. PubMed ID: 25696903
    [Abstract] [Full Text] [Related]

  • 59. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
    Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.
    Am J Kidney Dis; 2013 Sep 05; 62(3):591-4. PubMed ID: 23597859
    [Abstract] [Full Text] [Related]

  • 60. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.
    Circulation; 2011 Jan 18; 123(2):131-6. PubMed ID: 21200007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.